Pharmacia submits valdecoxib NDA

PHA submitted an NDA for its valdecoxib oral second generation COX-2 antagonist to

Read the full 130 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE